Skip to main content

Pluri Inc.

PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001158780

No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Pluri Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of PLUR: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders3842+4
Shares2.08M2.83M+752.5K (+36.2%)
Value$4.30M$3.48M−$824.8K (−19.2%)

New holders (7)

Institutions that held Pluri Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to PLUR in Q2 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC140,715$173.0K0.00%
Simplex Trading, LLC16,072$19.0K0.00%
BSW Wealth Partners14,937$18.0K0.00%
Eqis Capital Management, Inc.14,419$17.7K0.00%
Susquehanna International Group Ltd.11,137$14.0K0.00%
Kestra Advisory Services, LLC10,777$13.0K0.00%
Credit Suisse AG139$00.00%

Sold out (3)

Institutions that held Pluri Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of PLUR in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
TownSquare Capital, LLC23,938$50.0K
Halpern Financial, Inc.5,800$12.0K
Captrust Financial Advisors100$0